Sponsors

Human papillomavirus vaccination

Analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations.

CDC/Judy Schmidt; James Gathany

Published in the journal Cancer, the study illustrates some of the challenges in monitoring a vaccine’s impact during a time of concurrent changes in screening. More than half of high-grade cervical lesions that can lead to cancer are caused by persistent HPV infection that can be prevented if a person receives an HPV vaccine. Monitoring trends in the incidence of these lesions is helpful for evaluating the impact of HPV vaccination.

Latest Issues

Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
7 April, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026

39th International Symposium on Technical Innovations in Laboratory Hematology

Edinburgh International Convention Centre
17-19 April, 2026

ESCMID Global 2026

Messe München Munich, Germany
17-21 April, 2026